New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab
PMID: 29272353
Source: J Crohns Colitis
Publication date:
2025-07-24
Year:
2018
Abstract
NULL